General description
A 5 mg vial contains ~1 mg of protein.
Native very low density lipoproteins from human plasma. VLDL transports hepatic synthesized triglycerides and cholesterol. May counteract the inhibitory effect of glucocorticoids on arachidonic acid release and prostaglandin I2 formation in vascular smooth muscle cells. (Composition: 88-95% lipid; 5-12% protein. Note: 5 mg vial contains 1 mg of protein.)
Native very low density lipoproteins from human plasma. VLDL transports liver-synthesized triglycerides and cholesterol. May counteract the inhibitory effect of glucocorticoids on arachidonic acid release and prostaglandin I2 formation in vascular smooth muscle cells. Composition: 88-95% lipid; 5-12% protein.
Packaging
Please refer to vial label for lot-specific concentration.
Warning
Toxicity: Standard Handling (A)
Other Notes
Petrichenko, I., et al. 1993. Biochim. Biophys. Acta1166, 183.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Assay: ≥. 95% (of total lipoprotein content, electrophoresis). Quality Level: 100. form: liquid. manufacturer/tradename: Calbiochem®. . storage condition: do not freeze. shipped in: wet ice. storage temp.: 2-8°C. Storage Class Code: 11 - Combustible Solids. WGK: WGK 1. Flash Point(F): Not applicable. Flash Point(C): Not applicable.- UPC:
- 41181547
- Condition:
- New
- Weight:
- 1.00 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- 437647-5MG